A carregar...

Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity

The safety and feasibility of dendritic cell (DC)-based immunotherapies in cancer management have been well documented after more than twenty-five years of experimentation, and, by now, undeniably accepted. On the other hand, it is equally evident that DC-based vaccination as monotherapy did not ach...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Lamberti, María Julia, Nigro, Annunziata, Mentucci, Fátima María, Rumie Vittar, Natalia Belén, Casolaro, Vincenzo, Dal Col, Jessica
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7151083/
https://ncbi.nlm.nih.gov/pubmed/32178288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12030256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!